Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-12-22

Clinical Trial Update: An Innovative Non-invasive Acoustic Approach to Detect and Monitor Cerebral Vasospasm

View source ↗

Summary

A clinical trial evaluating a non-invasive acoustic method to detect and monitor cerebral vasospasm after subarachnoid hemorrhage has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: HeadSense Medical | Conditions: Sub Arachnoid Hemorrhage, Vasospasm | Status: WITHDRAWN